Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Abraham

Showing results (651-660 of 932) with videos related to

Pageof 94
Sort By:
Circulation|December 7, 2007
Direct left atrial pressure monitoring in ambulatory heart failure patients: initial experience with a new permanent implantable deviceJay Ritzema, Iain C Melton, A Mark Richards, et al.
European Journal of Heart Failure|October 11, 2018
Phrenic nerve stimulation to treat patients with central sleep apnoea and heart failureMaria Rosa Costanzo, Piotr Ponikowski, Andrew Coats, et al.
Pacing and Clinical Electrophysiology : PACE|February 14, 2015
Association of BNP and Troponin Levels with Outcome among Cardiac Resynchronization Therapy RecipientsAlaa A Shalaby, William T Abraham, Gregg C Fonarow, et al.
Journal of Cardiac Failure|May 10, 2011
Hemodynamic factors associated with acute decompensated heart failure: part 2--use in automated detectionPhilip B Adamson, Michael R Zile, Yong K Cho, et al.
Journal of Cardiac Failure|March 29, 2011
Hemodynamic factors associated with acute decompensated heart failure: part 1--insights into pathophysiologyMichael R Zile, Philip B Adamson, Yong K Cho, et al.
Journal of the American College of Cardiology|August 27, 2021
Device Therapy in Chronic Heart Failure: JACC State-of-the-Art ReviewMarat Fudim, William T Abraham, Ralph Stephan von Bardeleben, et al.
The Journal of Clinical Investigation|September 1, 1995
Angiotensin II formation in the intact human heart. Predominance of the angiotensin-converting enzyme pathwayL S Zisman, W T Abraham, G E Meixell, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 26, 2019
Cystine-glutamate antiporter xCT deficiency suppresses tumor growth while preserving antitumor immunityMichael D Arensman, Xiaoran S Yang, Danielle M Leahy, et al.
Journal of Cardiac Failure|August 30, 2008
Cardiac resynchronization therapy improves renal function in human heart failure with reduced glomerular filtration rateGuido Boerrigter, Lisa C Costello-Boerrigter, William T Abraham, et al.
American Heart Journal|July 2, 2005
Predictors of response to cardiac resynchronization therapy (PROSPECT)--study designCheuk-Man Yu, William T Abraham, Jeroen Bax, et al.
Pageof 94

Showing results (651-660 of 932) with videos related to

Sort By:
Pageof 94
Circulation|December 7, 2007
Direct left atrial pressure monitoring in ambulatory heart failure patients: initial experience with a new permanent implantable deviceJay Ritzema, Iain C Melton, A Mark Richards, et al.
European Journal of Heart Failure|October 11, 2018
Phrenic nerve stimulation to treat patients with central sleep apnoea and heart failureMaria Rosa Costanzo, Piotr Ponikowski, Andrew Coats, et al.
Pacing and Clinical Electrophysiology : PACE|February 14, 2015
Association of BNP and Troponin Levels with Outcome among Cardiac Resynchronization Therapy RecipientsAlaa A Shalaby, William T Abraham, Gregg C Fonarow, et al.
Journal of Cardiac Failure|May 10, 2011
Hemodynamic factors associated with acute decompensated heart failure: part 2--use in automated detectionPhilip B Adamson, Michael R Zile, Yong K Cho, et al.
Journal of Cardiac Failure|March 29, 2011
Hemodynamic factors associated with acute decompensated heart failure: part 1--insights into pathophysiologyMichael R Zile, Philip B Adamson, Yong K Cho, et al.
Journal of the American College of Cardiology|August 27, 2021
Device Therapy in Chronic Heart Failure: JACC State-of-the-Art ReviewMarat Fudim, William T Abraham, Ralph Stephan von Bardeleben, et al.
The Journal of Clinical Investigation|September 1, 1995
Angiotensin II formation in the intact human heart. Predominance of the angiotensin-converting enzyme pathwayL S Zisman, W T Abraham, G E Meixell, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 26, 2019
Cystine-glutamate antiporter xCT deficiency suppresses tumor growth while preserving antitumor immunityMichael D Arensman, Xiaoran S Yang, Danielle M Leahy, et al.
Journal of Cardiac Failure|August 30, 2008
Cardiac resynchronization therapy improves renal function in human heart failure with reduced glomerular filtration rateGuido Boerrigter, Lisa C Costello-Boerrigter, William T Abraham, et al.
American Heart Journal|July 2, 2005
Predictors of response to cardiac resynchronization therapy (PROSPECT)--study designCheuk-Man Yu, William T Abraham, Jeroen Bax, et al.
Pageof 94